APO Research
Talk to an analyst

APO RESEARCH · REPORT

Chronic Idiopathic Constipation Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Chronic Idiopathic Constipation Drugs Industry Growth and Trends Forecast to 2032

20 December 2025119 pages

Choose your research edition.

Industry ResearchChronic Idiopathic Constipation Drugs Industry Research Report 2026135 pages · $2,950 USDIndustry Growth & TrendsGlobal Chronic Idiopathic Constipation Drugs Industry Growth and Trends Forecast to 2032119 pages · $3,450 USDMarket StructureGlobal Chronic Idiopathic Constipation Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Chronic Idiopathic Constipation Drugs Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal Chronic Idiopathic Constipation Drugs Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Chronic Idiopathic Constipation Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Chronic Idiopathic Constipation Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Chronic Idiopathic Constipation Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Chronic Idiopathic Constipation Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Chronic Idiopathic Constipation Drugs include Sanofi, Merck, Eli Lilly, Pfizer, Glaxosmithkline, Bayer AG, Theravance Biopharma Inc, Synergy Pharmaceuticals and Sucampo Pharmaceuticals Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Chronic Idiopathic Constipation Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Chronic Idiopathic Constipation Drugs market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Chronic Idiopathic Constipation Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Chronic Idiopathic Constipation Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Chronic Idiopathic Constipation Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Chronic Idiopathic Constipation Drugs Market by Company

Sanofi

Merck

Eli Lilly

Pfizer

Glaxosmithkline

Bayer AG

Theravance Biopharma Inc

Synergy Pharmaceuticals

Sucampo Pharmaceuticals Inc

Salix Pharmaceuticals Ltd

Roche Holding AG

Progenics Pharmaceuticals Inc

Ironwood Pharmaceuticals Inc

Ferring International Center S.A

Daiichi Sankyo

Cosmo Pharmaceuticals SA

Chugai Pharmaceutical

Bausch Health

Allergens

Chronic Idiopathic Constipation Drugs Segment by Type

Linaclotide

Lubiprostone

Others

Chronic Idiopathic Constipation Drugs Segment by Application

Retail Pharmacies

Online Pharmacies

Hospital Pharmacies

Chronic Idiopathic Constipation Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chronic Idiopathic Constipation Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Chronic Idiopathic Constipation Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chronic Idiopathic Constipation Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Chronic Idiopathic Constipation Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Chronic Idiopathic Constipation Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Linaclotide Table 2. Major Company of Lubiprostone Table 3. Major Company of Others Table 4. Global Chronic Idiopathic Constipation Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Chronic Idiopathic Constipation Drugs Sales by Type (2021-2026) & (K Units) Table 6. Global Chronic Idiopathic Constipation Drugs Sales Market Share in Volume by Type (2021-2026) Table 7. Global Chronic Idiopathic Constipation Drugs Sales by Type (2021-2026) & (US$ Million) Table 8. Global Chronic Idiopathic Constipation Drugs Sales Market Share in Value by Type (2021-2026) Table 9. Global Chronic Idiopathic Constipation Drugs Price by Type (2021-2026) & (US$/Unit) Table 10. Global Chronic Idiopathic Constipation Drugs Sales by Type (2027-2032) & (K Units) Table 11. Global Chronic Idiopathic Constipation Drugs Sales Market Share in Volume by Type (2027-2032) Table 12. Global Chronic Idiopathic Constipation Drugs Sales by Type (2027-2032) & (US$ Million) Table 13. Global Chronic Idiopathic Constipation Drugs Sales Market Share in Value by Type (2027-2032) Table 14. Global Chronic Idiopathic Constipation Drugs Price by Type (2027-2032) & (US$/Unit) Table 15. North America Chronic Idiopathic Constipation Drugs Sales by Type (2021-2026) & (K Units) Table 16. North America Chronic Idiopathic Constipation Drugs Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Chronic Idiopathic Constipation Drugs Sales by Type (2021-2026) & (K Units) Table 18. Europe Chronic Idiopathic Constipation Drugs Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Chronic Idiopathic Constipation Drugs Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Chronic Idiopathic Constipation Drugs Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Chronic Idiopathic Constipation Drugs Sales by Type (2021-2026) & (K Units) Table 22. Latin America Chronic Idiopathic Constipation Drugs Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Chronic Idiopathic Constipation Drugs Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Chronic Idiopathic Constipation Drugs Sales by Type (2021-2026) & (US$ Million) Table 25. Chronic Idiopathic Constipation Drugs Industry Trends Table 26. Chronic Idiopathic Constipation Drugs Industry Drivers Table 27. Chronic Idiopathic Constipation Drugs Industry Opportunities and Challenges Table 28. Chronic Idiopathic Constipation Drugs Industry Restraints Table 29. Global Chronic Idiopathic Constipation Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Chronic Idiopathic Constipation Drugs Revenue Market Share by Company (2021-2026) Table 31. Global Chronic Idiopathic Constipation Drugs Sales by Company (2021-2026) & (K Units) Table 32. Global Chronic Idiopathic Constipation Drugs Sales Share by Company (2021-2026) Table 33. Global Chronic Idiopathic Constipation Drugs Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Chronic Idiopathic Constipation Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Chronic Idiopathic Constipation Drugs Major Company Production Sites and Headquarters Table 36. Global Chronic Idiopathic Constipation Drugs Company, Product Type & Application Table 37. Global Chronic Idiopathic Constipation Drugs Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Chronic Idiopathic Constipation Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Chronic Idiopathic Constipation Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Chronic Idiopathic Constipation Drugs Sales by Region (2021-2026) & (K Units) Table 42. Global Chronic Idiopathic Constipation Drugs Sales Market Share in Volume by Region (2021-2026) Table 43. Global Chronic Idiopathic Constipation Drugs Sales by Region (2021-2026) & (US$ Million) Table 44. Global Chronic Idiopathic Constipation Drugs Sales Market Share in Value by Region (2021-2026) Table 45. Global Chronic Idiopathic Constipation Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Chronic Idiopathic Constipation Drugs Sales by Region (2027-2032) & (K Units) Table 47. Global Chronic Idiopathic Constipation Drugs Sales Market Share in Volume by Region (2027-2032) Table 48. Global Chronic Idiopathic Constipation Drugs Sales by Region (2027-2032) & (US$ Million) Table 49. Global Chronic Idiopathic Constipation Drugs Sales Market Share in Value by Region (2027-2032) Table 50. Global Chronic Idiopathic Constipation Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Chronic Idiopathic Constipation Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Chronic Idiopathic Constipation Drugs Sales by Application (2021-2026) & (K Units) Table 53. Global Chronic Idiopathic Constipation Drugs Sales Market Share in Volume by Application (2021-2026) Table 54. Global Chronic Idiopathic Constipation Drugs Sales by Application (2021-2026) & (US$ Million) Table 55. Global Chronic Idiopathic Constipation Drugs Sales Market Share in Value by Application (2021-2026) Table 56. Global Chronic Idiopathic Constipation Drugs Price by Application (2021-2026) & (US$/Unit) Table 57. Global Chronic Idiopathic Constipation Drugs Sales by Application (2027-2032) & (K Units) Table 58. Global Chronic Idiopathic Constipation Drugs Sales Market Share in Volume by Application (2027-2032) Table 59. Global Chronic Idiopathic Constipation Drugs Sales by Application (2027-2032) & (US$ Million) Table 60. Global Chronic Idiopathic Constipation Drugs Sales Market Share in Value by Application (2027-2032) Table 61. Global Chronic Idiopathic Constipation Drugs Price by Application (2027-2032) & (US$/Unit) Table 62. North America Chronic Idiopathic Constipation Drugs Sales by Application (2021-2026) & (K Units) Table 63. North America Chronic Idiopathic Constipation Drugs Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Chronic Idiopathic Constipation Drugs Sales by Application (2021-2026) & (K Units) Table 65. Europe Chronic Idiopathic Constipation Drugs Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Chronic Idiopathic Constipation Drugs Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Chronic Idiopathic Constipation Drugs Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Chronic Idiopathic Constipation Drugs Sales by Application (2021-2026) & (K Units) Table 69. Latin America Chronic Idiopathic Constipation Drugs Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Chronic Idiopathic Constipation Drugs Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Chronic Idiopathic Constipation Drugs Sales by Application (2021-2026) & (US$ Million) Table 72. Sanofi Company Information Table 73. Sanofi Business Overview Table 74. Sanofi Chronic Idiopathic Constipation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Sanofi Chronic Idiopathic Constipation Drugs Product Portfolio Table 76. Sanofi Recent Development Table 77. Merck Company Information Table 78. Merck Business Overview Table 79. Merck Chronic Idiopathic Constipation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Merck Chronic Idiopathic Constipation Drugs Product Portfolio Table 81. Merck Recent Development Table 82. Eli Lilly Company Information Table 83. Eli Lilly Business Overview Table 84. Eli Lilly Chronic Idiopathic Constipation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Eli Lilly Chronic Idiopathic Constipation Drugs Product Portfolio Table 86. Eli Lilly Recent Development Table 87. Pfizer Company Information Table 88. Pfizer Business Overview Table 89. Pfizer Chronic Idiopathic Constipation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Pfizer Chronic Idiopathic Constipation Drugs Product Portfolio Table 91. Pfizer Recent Development Table 92. Glaxosmithkline Company Information Table 93. Glaxosmithkline Business Overview Table 94. Glaxosmithkline Chronic Idiopathic Constipation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Glaxosmithkline Chronic Idiopathic Constipation Drugs Product Portfolio Table 96. Glaxosmithkline Recent Development Table 97. Bayer AG Company Information Table 98. Bayer AG Business Overview Table 99. Bayer AG Chronic Idiopathic Constipation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Bayer AG Chronic Idiopathic Constipation Drugs Product Portfolio Table 101. Bayer AG Recent Development Table 102. Theravance Biopharma Inc Company Information Table 103. Theravance Biopharma Inc Business Overview Table 104. Theravance Biopharma Inc Chronic Idiopathic Constipation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Theravance Biopharma Inc Chronic Idiopathic Constipation Drugs Product Portfolio Table 106. Theravance Biopharma Inc Recent Development Table 107. Synergy Pharmaceuticals Company Information Table 108. Synergy Pharmaceuticals Business Overview Table 109. Synergy Pharmaceuticals Chronic Idiopathic Constipation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Synergy Pharmaceuticals Chronic Idiopathic Constipation Drugs Product Portfolio Table 111. Synergy Pharmaceuticals Recent Development Table 112. Sucampo Pharmaceuticals Inc Company Information Table 113. Sucampo Pharmaceuticals Inc Business Overview Table 114. Sucampo Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Sucampo Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Product Portfolio Table 116. Sucampo Pharmaceuticals Inc Recent Development Table 117. Salix Pharmaceuticals Ltd Company Information Table 118. Salix Pharmaceuticals Ltd Business Overview Table 119. Salix Pharmaceuticals Ltd Chronic Idiopathic Constipation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Salix Pharmaceuticals Ltd Chronic Idiopathic Constipation Drugs Product Portfolio Table 121. Salix Pharmaceuticals Ltd Recent Development Table 122. Roche Holding AG Company Information Table 123. Roche Holding AG Business Overview Table 124. Roche Holding AG Chronic Idiopathic Constipation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Roche Holding AG Chronic Idiopathic Constipation Drugs Product Portfolio Table 126. Roche Holding AG Recent Development Table 127. Progenics Pharmaceuticals Inc Company Information Table 128. Progenics Pharmaceuticals Inc Business Overview Table 129. Progenics Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Progenics Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Product Portfolio Table 131. Progenics Pharmaceuticals Inc Recent Development Table 132. Ironwood Pharmaceuticals Inc Company Information Table 133. Ironwood Pharmaceuticals Inc Business Overview Table 134. Ironwood Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Ironwood Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Product Portfolio Table 136. Ironwood Pharmaceuticals Inc Recent Development Table 137. Ferring International Center S.A Company Information Table 138. Ferring International Center S.A Business Overview Table 139. Ferring International Center S.A Chronic Idiopathic Constipation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. Ferring International Center S.A Chronic Idiopathic Constipation Drugs Product Portfolio Table 141. Ferring International Center S.A Recent Development Table 142. Daiichi Sankyo Company Information Table 143. Daiichi Sankyo Business Overview Table 144. Daiichi Sankyo Chronic Idiopathic Constipation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 145. Daiichi Sankyo Chronic Idiopathic Constipation Drugs Product Portfolio Table 146. Daiichi Sankyo Recent Development Table 147. Cosmo Pharmaceuticals SA Company Information Table 148. Cosmo Pharmaceuticals SA Business Overview Table 149. Cosmo Pharmaceuticals SA Chronic Idiopathic Constipation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 150. Cosmo Pharmaceuticals SA Chronic Idiopathic Constipation Drugs Product Portfolio Table 151. Cosmo Pharmaceuticals SA Recent Development Table 152. Chugai Pharmaceutical Company Information Table 153. Chugai Pharmaceutical Business Overview Table 154. Chugai Pharmaceutical Chronic Idiopathic Constipation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 155. Chugai Pharmaceutical Chronic Idiopathic Constipation Drugs Product Portfolio Table 156. Chugai Pharmaceutical Recent Development Table 157. Bausch Health Company Information Table 158. Bausch Health Business Overview Table 159. Bausch Health Chronic Idiopathic Constipation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 160. Bausch Health Chronic Idiopathic Constipation Drugs Product Portfolio Table 161. Bausch Health Recent Development Table 162. Allergens Company Information Table 163. Allergens Business Overview Table 164. Allergens Chronic Idiopathic Constipation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 165. Allergens Chronic Idiopathic Constipation Drugs Product Portfolio Table 166. Allergens Recent Development Table 167. North America Chronic Idiopathic Constipation Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 168. North America Chronic Idiopathic Constipation Drugs Sales by Country (2021-2026) & (K Units) Table 169. North America Chronic Idiopathic Constipation Drugs Sales Market Share by Country (2021-2026) Table 170. North America Chronic Idiopathic Constipation Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 171. North America Chronic Idiopathic Constipation Drugs Sales Market Share Forecast by Country (2027-2032) Table 172. North America Chronic Idiopathic Constipation Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 173. North America Chronic Idiopathic Constipation Drugs Market Size by Country (2021-2026) & (US$ Million) Table 174. North America Chronic Idiopathic Constipation Drugs Market Share by Country (2021-2026) Table 175. North America Chronic Idiopathic Constipation Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 176. North America Chronic Idiopathic Constipation Drugs Market Share Forecast by Country (2027-2032) Table 177. Europe Chronic Idiopathic Constipation Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 178. Europe Chronic Idiopathic Constipation Drugs Sales by Country (2021-2026) & (K Units) Table 179. Europe Chronic Idiopathic Constipation Drugs Sales Market Share by Country (2021-2026) Table 180. Europe Chronic Idiopathic Constipation Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 181. Europe Chronic Idiopathic Constipation Drugs Sales Market Share Forecast by Country (2027-2032) Table 182. Europe Chronic Idiopathic Constipation Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 183. Europe Chronic Idiopathic Constipation Drugs Market Size by Country (2021-2026) & (US$ Million) Table 184. Europe Chronic Idiopathic Constipation Drugs Market Share by Country (2021-2026) Table 185. Europe Chronic Idiopathic Constipation Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 186. Europe Chronic Idiopathic Constipation Drugs Market Share Forecast by Country (2027-2032) Table 187. Asia-Pacific Chronic Idiopathic Constipation Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 188. Asia-Pacific Chronic Idiopathic Constipation Drugs Sales by Country (2021-2026) & (K Units) Table 189. Asia-Pacific Chronic Idiopathic Constipation Drugs Sales Market Share by Country (2021-2026) Table 190. Asia-Pacific Chronic Idiopathic Constipation Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 191. Asia-Pacific Chronic Idiopathic Constipation Drugs Sales Market Share Forecast by Country (2027-2032) Table 192. Asia-Pacific Chronic Idiopathic Constipation Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 193. Asia-Pacific Chronic Idiopathic Constipation Drugs Market Size by Country (2021-2026) & (US$ Million) Table 194. Asia-Pacific Chronic Idiopathic Constipation Drugs Market Share by Country (2021-2026) Table 195. Asia-Pacific Chronic Idiopathic Constipation Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 196. Asia-Pacific Chronic Idiopathic Constipation Drugs Market Share Forecast by Country (2027-2032) Table 197. Latin America Chronic Idiopathic Constipation Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 198. Latin America Chronic Idiopathic Constipation Drugs Sales by Country (2021-2026) & (K Units) Table 199. Latin America Chronic Idiopathic Constipation Drugs Sales Market Share by Country (2021-2026) Table 200. Latin America Chronic Idiopathic Constipation Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 201. Latin America Chronic Idiopathic Constipation Drugs Sales Market Share Forecast by Country (2027-2032) Table 202. Latin America Chronic Idiopathic Constipation Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 203. Latin America Chronic Idiopathic Constipation Drugs Market Size by Country (2021-2026) & (US$ Million) Table 204. Latin America Chronic Idiopathic Constipation Drugs Market Share by Country (2021-2026) Table 205. Latin America Chronic Idiopathic Constipation Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 206. Latin America Chronic Idiopathic Constipation Drugs Market Share Forecast by Country (2027-2032) Table 207. Middle East and Africa Chronic Idiopathic Constipation Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 208. Middle East and Africa Chronic Idiopathic Constipation Drugs Sales by Country (2021-2026) & (K Units) Table 209. Middle East and Africa Chronic Idiopathic Constipation Drugs Sales Market Share by Country (2021-2026) Table 210. Middle East and Africa Chronic Idiopathic Constipation Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 211. Middle East and Africa Chronic Idiopathic Constipation Drugs Sales Market Share Forecast by Country (2027-2032) Table 212. Middle East and Africa Chronic Idiopathic Constipation Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 213. Middle East and Africa Chronic Idiopathic Constipation Drugs Market Size by Country (2021-2026) & (US$ Million) Table 214. Middle East and Africa Chronic Idiopathic Constipation Drugs Market Share by Country (2021-2026) Table 215. Middle East and Africa Chronic Idiopathic Constipation Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 216. Middle East and Africa Chronic Idiopathic Constipation Drugs Market Share Forecast by Country (2027-2032) Table 217. Key Raw Materials Table 218. Raw Materials Key Suppliers Table 219. Chronic Idiopathic Constipation Drugs Distributors List Table 220. Chronic Idiopathic Constipation Drugs Customers List Table 221. Research Programs/Design for This Report Table 222. Authors List of This Report Table 223. Secondary Sources Table 224. Primary Sources List of Figures Figure 1. Chronic Idiopathic Constipation Drugs Image Figure 2. Global Chronic Idiopathic Constipation Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Chronic Idiopathic Constipation Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Chronic Idiopathic Constipation Drugs Sales (2021-2032) & (K Units) Figure 5. Linaclotide Image Figure 6. Global Linaclotide Sales YoY Growth (2021-2032) & (K Units) Figure 7. Lubiprostone Image Figure 8. Global Lubiprostone Sales YoY Growth (2021-2032) & (K Units) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Chronic Idiopathic Constipation Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Chronic Idiopathic Constipation Drugs Market Share by Type 2025 VS 2032 Figure 13. North America Chronic Idiopathic Constipation Drugs Sales Market Share in Volume by Type in 2025 Figure 14. North America Chronic Idiopathic Constipation Drugs Sales Market Share in Value by Type in 2025 Figure 15. Europe Chronic Idiopathic Constipation Drugs Sales Market Share in Volume by Type in 2025 Figure 16. Europe Chronic Idiopathic Constipation Drugs Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Chronic Idiopathic Constipation Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Chronic Idiopathic Constipation Drugs Sales Market Share in Value by Type in 2025 Figure 19. Latin America Chronic Idiopathic Constipation Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Chronic Idiopathic Constipation Drugs Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Chronic Idiopathic Constipation Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Chronic Idiopathic Constipation Drugs Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Chronic Idiopathic Constipation Drugs Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Retail Pharmacies Image Figure 26. Global Retail Pharmacies Sales YoY Growth (2021-2032) & (K Units) Figure 27. Online Pharmacies Image Figure 28. Global Online Pharmacies Sales YoY Growth (2021-2032) & (K Units) Figure 29. Hospital Pharmacies Image Figure 30. Global Hospital Pharmacies Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Chronic Idiopathic Constipation Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Chronic Idiopathic Constipation Drugs Market Share by Application 2025 VS 2032 Figure 33. North America Chronic Idiopathic Constipation Drugs Sales Market Share in Volume by Application in 2025 Figure 34. North America Chronic Idiopathic Constipation Drugs Sales Market Share in Value by Application in 2025 Figure 35. Europe Chronic Idiopathic Constipation Drugs Sales Market Share in Volume by Application in 2025 Figure 36. Europe Chronic Idiopathic Constipation Drugs Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Chronic Idiopathic Constipation Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Chronic Idiopathic Constipation Drugs Sales Market Share in Value by Application in 2025 Figure 39. Latin America Chronic Idiopathic Constipation Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Chronic Idiopathic Constipation Drugs Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Chronic Idiopathic Constipation Drugs Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Chronic Idiopathic Constipation Drugs Sales Market Share in Value by Application in 2025 Figure 43. North America Chronic Idiopathic Constipation Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Chronic Idiopathic Constipation Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Chronic Idiopathic Constipation Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Chronic Idiopathic Constipation Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Chronic Idiopathic Constipation Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Chronic Idiopathic Constipation Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Chronic Idiopathic Constipation Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Chronic Idiopathic Constipation Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Chronic Idiopathic Constipation Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Chronic Idiopathic Constipation Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Chronic Idiopathic Constipation Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Chronic Idiopathic Constipation Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Chronic Idiopathic Constipation Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Chronic Idiopathic Constipation Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Chronic Idiopathic Constipation Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Chronic Idiopathic Constipation Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Chronic Idiopathic Constipation Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Chronic Idiopathic Constipation Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Chronic Idiopathic Constipation Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Chronic Idiopathic Constipation Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Chronic Idiopathic Constipation Drugs Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Chronic Idiopathic Constipation Drugs Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Linaclotide
  • Lubiprostone
  • Others
Applications
  • Retail Pharmacies
  • Online Pharmacies
  • Hospital Pharmacies
Companies covered
  • Sanofi
  • Merck
  • Eli Lilly
  • Pfizer
  • Glaxosmithkline
  • Bayer AG
  • Theravance Biopharma Inc
  • Synergy Pharmaceuticals
  • Sucampo Pharmaceuticals Inc
  • Salix Pharmaceuticals Ltd
  • Roche Holding AG
  • Progenics Pharmaceuticals Inc
  • Ironwood Pharmaceuticals Inc
  • Ferring International Center S.A
  • Daiichi Sankyo
  • Cosmo Pharmaceuticals SA
  • Chugai Pharmaceutical
  • Bausch Health
  • Allergens

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Chronic Idiopathic Constipation Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Chronic Idiopathic Constipation Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Chronic Idiopathic Constipation Drugs Market by Type
  6. 1.3.1 Linaclotide
  7. 1.3.2 Lubiprostone
  8. 1.3.3 Others
  9. 1.4 Global Chronic Idiopathic Constipation Drugs Market Size by Type
  10. 1.4.1 Global Chronic Idiopathic Constipation Drugs Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Chronic Idiopathic Constipation Drugs Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Chronic Idiopathic Constipation Drugs Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Chronic Idiopathic Constipation Drugs Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Chronic Idiopathic Constipation Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Chronic Idiopathic Constipation Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Chronic Idiopathic Constipation Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Chronic Idiopathic Constipation Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Chronic Idiopathic Constipation Drugs Industry Trends
  2. 2.2 Chronic Idiopathic Constipation Drugs Industry Drivers
  3. 2.3 Chronic Idiopathic Constipation Drugs Industry Opportunities and Challenges
  4. 2.4 Chronic Idiopathic Constipation Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Chronic Idiopathic Constipation Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Chronic Idiopathic Constipation Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Chronic Idiopathic Constipation Drugs Price (2021-2026)
  4. 3.4 Global Chronic Idiopathic Constipation Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Chronic Idiopathic Constipation Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Chronic Idiopathic Constipation Drugs Company, Product Type & Application
  7. 3.7 Global Chronic Idiopathic Constipation Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Chronic Idiopathic Constipation Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Chronic Idiopathic Constipation Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Chronic Idiopathic Constipation Drugs Tier 1, Tier 2, and Tier 3
4 Chronic Idiopathic Constipation Drugs Regional Status and Outlook
  1. 4.1 Global Chronic Idiopathic Constipation Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Chronic Idiopathic Constipation Drugs Historic Market Size by Region
  3. 4.2.1 Global Chronic Idiopathic Constipation Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Chronic Idiopathic Constipation Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Chronic Idiopathic Constipation Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Chronic Idiopathic Constipation Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Chronic Idiopathic Constipation Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Chronic Idiopathic Constipation Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Chronic Idiopathic Constipation Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Chronic Idiopathic Constipation Drugs by Application
  1. 5.1 Chronic Idiopathic Constipation Drugs Market by Application
  2. 5.1.1 Retail Pharmacies
  3. 5.1.2 Online Pharmacies
  4. 5.1.3 Hospital Pharmacies
  5. 5.2 Global Chronic Idiopathic Constipation Drugs Market Size by Application
  6. 5.2.1 Global Chronic Idiopathic Constipation Drugs Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Chronic Idiopathic Constipation Drugs Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Chronic Idiopathic Constipation Drugs Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Chronic Idiopathic Constipation Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Chronic Idiopathic Constipation Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Chronic Idiopathic Constipation Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Chronic Idiopathic Constipation Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Chronic Idiopathic Constipation Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sanofi
  2. 6.1.1 Sanofi Company Information
  3. 6.1.2 Sanofi Business Overview
  4. 6.1.3 Sanofi Chronic Idiopathic Constipation Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sanofi Chronic Idiopathic Constipation Drugs Product Portfolio
  6. 6.1.5 Sanofi Recent Developments
  7. 6.2 Merck
  8. 6.2.1 Merck Company Information
  9. 6.2.2 Merck Business Overview
  10. 6.2.3 Merck Chronic Idiopathic Constipation Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Merck Chronic Idiopathic Constipation Drugs Product Portfolio
  12. 6.2.5 Merck Recent Developments
  13. 6.3 Eli Lilly
  14. 6.3.1 Eli Lilly Company Information
  15. 6.3.2 Eli Lilly Business Overview
  16. 6.3.3 Eli Lilly Chronic Idiopathic Constipation Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Eli Lilly Chronic Idiopathic Constipation Drugs Product Portfolio
  18. 6.3.5 Eli Lilly Recent Developments
  19. 6.4 Pfizer
  20. 6.4.1 Pfizer Company Information
  21. 6.4.2 Pfizer Business Overview
  22. 6.4.3 Pfizer Chronic Idiopathic Constipation Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Pfizer Chronic Idiopathic Constipation Drugs Product Portfolio
  24. 6.4.5 Pfizer Recent Developments
  25. 6.5 Glaxosmithkline
  26. 6.5.1 Glaxosmithkline Company Information
  27. 6.5.2 Glaxosmithkline Business Overview
  28. 6.5.3 Glaxosmithkline Chronic Idiopathic Constipation Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Glaxosmithkline Chronic Idiopathic Constipation Drugs Product Portfolio
  30. 6.5.5 Glaxosmithkline Recent Developments
  31. 6.6 Bayer AG
  32. 6.6.1 Bayer AG Company Information
  33. 6.6.2 Bayer AG Business Overview
  34. 6.6.3 Bayer AG Chronic Idiopathic Constipation Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Bayer AG Chronic Idiopathic Constipation Drugs Product Portfolio
  36. 6.6.5 Bayer AG Recent Developments
  37. 6.7 Theravance Biopharma Inc
  38. 6.7.1 Theravance Biopharma Inc Company Information
  39. 6.7.2 Theravance Biopharma Inc Business Overview
  40. 6.7.3 Theravance Biopharma Inc Chronic Idiopathic Constipation Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Theravance Biopharma Inc Chronic Idiopathic Constipation Drugs Product Portfolio
  42. 6.7.5 Theravance Biopharma Inc Recent Developments
  43. 6.8 Synergy Pharmaceuticals
  44. 6.8.1 Synergy Pharmaceuticals Company Information
  45. 6.8.2 Synergy Pharmaceuticals Business Overview
  46. 6.8.3 Synergy Pharmaceuticals Chronic Idiopathic Constipation Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Synergy Pharmaceuticals Chronic Idiopathic Constipation Drugs Product Portfolio
  48. 6.8.5 Synergy Pharmaceuticals Recent Developments
  49. 6.9 Sucampo Pharmaceuticals Inc
  50. 6.9.1 Sucampo Pharmaceuticals Inc Company Information
  51. 6.9.2 Sucampo Pharmaceuticals Inc Business Overview
  52. 6.9.3 Sucampo Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Sucampo Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Product Portfolio
  54. 6.9.5 Sucampo Pharmaceuticals Inc Recent Developments
  55. 6.10 Salix Pharmaceuticals Ltd
  56. 6.10.1 Salix Pharmaceuticals Ltd Company Information
  57. 6.10.2 Salix Pharmaceuticals Ltd Business Overview
  58. 6.10.3 Salix Pharmaceuticals Ltd Chronic Idiopathic Constipation Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Salix Pharmaceuticals Ltd Chronic Idiopathic Constipation Drugs Product Portfolio
  60. 6.10.5 Salix Pharmaceuticals Ltd Recent Developments
  61. 6.11 Roche Holding AG
  62. 6.11.1 Roche Holding AG Company Information
  63. 6.11.2 Roche Holding AG Business Overview
  64. 6.11.3 Roche Holding AG Chronic Idiopathic Constipation Drugs Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Roche Holding AG Chronic Idiopathic Constipation Drugs Product Portfolio
  66. 6.11.5 Roche Holding AG Recent Developments
  67. 6.12 Progenics Pharmaceuticals Inc
  68. 6.12.1 Progenics Pharmaceuticals Inc Company Information
  69. 6.12.2 Progenics Pharmaceuticals Inc Business Overview
  70. 6.12.3 Progenics Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Progenics Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Product Portfolio
  72. 6.12.5 Progenics Pharmaceuticals Inc Recent Developments
  73. 6.13 Ironwood Pharmaceuticals Inc
  74. 6.13.1 Ironwood Pharmaceuticals Inc Company Information
  75. 6.13.2 Ironwood Pharmaceuticals Inc Business Overview
  76. 6.13.3 Ironwood Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Ironwood Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Product Portfolio
  78. 6.13.5 Ironwood Pharmaceuticals Inc Recent Developments
  79. 6.14 Ferring International Center S.A
  80. 6.14.1 Ferring International Center S.A Company Information
  81. 6.14.2 Ferring International Center S.A Business Overview
  82. 6.14.3 Ferring International Center S.A Chronic Idiopathic Constipation Drugs Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Ferring International Center S.A Chronic Idiopathic Constipation Drugs Product Portfolio
  84. 6.14.5 Ferring International Center S.A Recent Developments
  85. 6.15 Daiichi Sankyo
  86. 6.15.1 Daiichi Sankyo Company Information
  87. 6.15.2 Daiichi Sankyo Business Overview
  88. 6.15.3 Daiichi Sankyo Chronic Idiopathic Constipation Drugs Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Daiichi Sankyo Chronic Idiopathic Constipation Drugs Product Portfolio
  90. 6.15.5 Daiichi Sankyo Recent Developments
  91. 6.16 Cosmo Pharmaceuticals SA
  92. 6.16.1 Cosmo Pharmaceuticals SA Company Information
  93. 6.16.2 Cosmo Pharmaceuticals SA Business Overview
  94. 6.16.3 Cosmo Pharmaceuticals SA Chronic Idiopathic Constipation Drugs Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Cosmo Pharmaceuticals SA Chronic Idiopathic Constipation Drugs Product Portfolio
  96. 6.16.5 Cosmo Pharmaceuticals SA Recent Developments
  97. 6.17 Chugai Pharmaceutical
  98. 6.17.1 Chugai Pharmaceutical Company Information
  99. 6.17.2 Chugai Pharmaceutical Business Overview
  100. 6.17.3 Chugai Pharmaceutical Chronic Idiopathic Constipation Drugs Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Chugai Pharmaceutical Chronic Idiopathic Constipation Drugs Product Portfolio
  102. 6.17.5 Chugai Pharmaceutical Recent Developments
  103. 6.18 Bausch Health
  104. 6.18.1 Bausch Health Company Information
  105. 6.18.2 Bausch Health Business Overview
  106. 6.18.3 Bausch Health Chronic Idiopathic Constipation Drugs Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Bausch Health Chronic Idiopathic Constipation Drugs Product Portfolio
  108. 6.18.5 Bausch Health Recent Developments
  109. 6.19 Allergens
  110. 6.19.1 Allergens Company Information
  111. 6.19.2 Allergens Business Overview
  112. 6.19.3 Allergens Chronic Idiopathic Constipation Drugs Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Allergens Chronic Idiopathic Constipation Drugs Product Portfolio
  114. 6.19.5 Allergens Recent Developments
7 North America by Country
  1. 7.1 North America Chronic Idiopathic Constipation Drugs Sales by Country
  2. 7.1.1 North America Chronic Idiopathic Constipation Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Chronic Idiopathic Constipation Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Chronic Idiopathic Constipation Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Chronic Idiopathic Constipation Drugs Market Size by Country
  6. 7.2.1 North America Chronic Idiopathic Constipation Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Chronic Idiopathic Constipation Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Chronic Idiopathic Constipation Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Chronic Idiopathic Constipation Drugs Sales by Country
  2. 8.1.1 Europe Chronic Idiopathic Constipation Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Chronic Idiopathic Constipation Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Chronic Idiopathic Constipation Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Chronic Idiopathic Constipation Drugs Market Size by Country
  6. 8.2.1 Europe Chronic Idiopathic Constipation Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Chronic Idiopathic Constipation Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Chronic Idiopathic Constipation Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Chronic Idiopathic Constipation Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Chronic Idiopathic Constipation Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Chronic Idiopathic Constipation Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Chronic Idiopathic Constipation Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Chronic Idiopathic Constipation Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Chronic Idiopathic Constipation Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Chronic Idiopathic Constipation Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Chronic Idiopathic Constipation Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Chronic Idiopathic Constipation Drugs Sales by Country
  2. 10.1.1 South America Chronic Idiopathic Constipation Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Chronic Idiopathic Constipation Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Chronic Idiopathic Constipation Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Chronic Idiopathic Constipation Drugs Market Size by Country
  6. 10.2.1 South America Chronic Idiopathic Constipation Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Chronic Idiopathic Constipation Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Chronic Idiopathic Constipation Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Chronic Idiopathic Constipation Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Chronic Idiopathic Constipation Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Chronic Idiopathic Constipation Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Chronic Idiopathic Constipation Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Chronic Idiopathic Constipation Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Chronic Idiopathic Constipation Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Chronic Idiopathic Constipation Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Chronic Idiopathic Constipation Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Chronic Idiopathic Constipation Drugs Value Chain Analysis
  2. 12.1.1 Chronic Idiopathic Constipation Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Chronic Idiopathic Constipation Drugs Production Mode & Process
  7. 12.2 Chronic Idiopathic Constipation Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Chronic Idiopathic Constipation Drugs Distributors
  10. 12.2.3 Chronic Idiopathic Constipation Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst